Literature DB >> 1100537

Assessment and treatment of abstinence in the infant of the drug-dependent mother.

L P Finnegan, R E Kron, J F Connaughton, J P Emich.   

Abstract

To accomplish the assessment and treatment of abstinence in the infant of the drug dependent mother, a scoring system has been devised for use as a clinical and research tool. The score monitors the passively addicted infant in a more comprehensive and precise way than has previously been described, and permits us to be more objective in our clinical estimates of the abstinence syndrome. Further, this scoring system has been used by relating it to the dosage schedule of phenobarbital or paregoric as part of an ongoing research project designed to test the comparative usefulness of recommended treatments for neonates with abstinence symptoms. It has been found useful also in following the progression or diminution of symptomatology before, during and after drug therapy. Moreover, the scoring system provides a basis for developing uniform criteria for the assessment and treatment of the neonate of the addicted mother.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1100537

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Biopharm        ISSN: 0340-0026


  39 in total

1.  Measurement of movement is an objective method to assist in assessment of opiate withdrawal in newborns.

Authors:  C O'Brien; R Hunt; H E Jeffery
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-07       Impact factor: 5.747

2.  Neonatal abstinence syndrome: a policy perspective.

Authors:  I J Chasnoff; S Gardner
Journal:  J Perinatol       Date:  2015-08       Impact factor: 2.521

3.  What is the best evidence based management of neonatal abstinence syndrome?

Authors:  N Nandakumar; V S Sankar
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-11       Impact factor: 5.747

4.  Prenatal cocaine use and maternal depression: effects on infant neurobehavior.

Authors:  Amy L Salisbury; Barry M Lester; Ronald Seifer; Linda Lagasse; Charles R Bauer; Seetha Shankaran; Henrietta Bada; Linda Wright; Jing Liu; Ken Poole
Journal:  Neurotoxicol Teratol       Date:  2006-12-14       Impact factor: 3.763

5.  Serotonin syndrome in a breast-fed neonate.

Authors:  Rachel Morris; Jean Matthes
Journal:  BMJ Case Rep       Date:  2015-05-06

6.  Neonatal Abstinence Syndrome: Leveraging Health Information Technology to Develop a Data-Driven National Policy Approach.

Authors:  Shahla M Jilani; Brett P Giroir
Journal:  Public Health Rep       Date:  2020-02-06       Impact factor: 2.792

7.  Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women.

Authors:  Verena Metz; Reinhold Jagsch; Nina Ebner; Johanna Würzl; Anna Pribasnig; Constantin Aschauer; Gabriele Fischer
Journal:  Hum Psychopharmacol       Date:  2011-08-08       Impact factor: 1.672

8.  Prescription opioid epidemic and infant outcomes.

Authors:  Stephen W Patrick; Judith Dudley; Peter R Martin; Frank E Harrell; Michael D Warren; Katherine E Hartmann; E Wesley Ely; Carlos G Grijalva; William O Cooper
Journal:  Pediatrics       Date:  2015-04-13       Impact factor: 7.124

9.  Managing infants born to mothers who have used opioids during pregnancy.

Authors:  Thierry Lacaze-Masmonteil; Pat O'Flaherty
Journal:  Paediatr Child Health       Date:  2018-05-11       Impact factor: 2.253

10.  Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial.

Authors:  Alexander G Agthe; George R Kim; Kay B Mathias; Craig W Hendrix; Raul Chavez-Valdez; Lauren Jansson; Tamorah R Lewis; Myron Yaster; Estelle B Gauda
Journal:  Pediatrics       Date:  2009-04-27       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.